Philip D. Ambery - Publications

Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy in CKD.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 04, 2026

Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

Journal: Canadian journal of physiology and pharmacology

Published: June 30, 2026

Exercise treadmill testing for efficacy evaluation in randomized, controlled trials.

Journal: American heart journal

Published: January 08, 2026

A machine learning approach to non-invasive prediction of hepatic decompensation in compensated advanced chronic liver disease: the CIRI model.

Journal: Journal of hepatology

Published: December 11, 2025

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial.

Journal: Cardiovascular diabetology

Published: April 28, 2025

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon-like peptide-1 and glucagon receptor in healthy subjects.

Journal: British journal of clinical pharmacology

Published: March 06, 2025

Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes.

Journal: Scientific reports

Published: November 10, 2024

Co-localization of the sodium-glucose co-transporter-2 channel (SGLT-2) with endothelin ETA and ETB receptors in human cardiorenal tissue.

Journal: Bioscience reports

Published: May 08, 2024

A comprehensive analysis of liver safety across zibotentan oncology trials: knowledge of the past offers new perspectives on the present.

Journal: Expert opinion on drug safety

Published: March 12, 2024

Anticoagulant prescribing trends, bleeding events, and reversal agent use in pediatric patients: A retrospective, real-world study.

Journal: PloS one

Published: December 07, 2023

The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial.

Journal: British journal of clinical pharmacology

Published: December 07, 2023

The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial.

Journal: British journal of pharmacology

Published: November 03, 2023